Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.51 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.44 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.41 |
| ▸ | PRKDC | P78527 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 6/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | CDC14B | O60729 | 1/20 | 0.38 |
| ▸ | CDC14A | Q9UNH5 | 1/20 | 0.38 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.37 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25645968 | 0.97 | ALOX5 (0.52) | ALOX5GGPS1PTGES2PRKDCMAPT | |
| SCHEMBL21148503 | 0.96 | ALOX5 (0.52) | ALOX5GGPS1PTGES2PRKDCMAPT | |
| SCHEMBL24318114 | 0.95 | ALOX5 (0.47) | ALOX5GGPS1PTGES2PRKDCMAPT | |
| SCHEMBL23820765 | 0.95 | ALOX5 (0.48) | ALOX5GGPS1PTGES2PRKDCMAPT | |
| SCHEMBL21784787 | 0.94 | ALOX5 (0.46) | ALOX5GGPS1PTGES2PRKDCMAPT | |
| SCHEMBL23349415 | 0.94 | ALOX5 (0.51) | ALOX5GGPS1PTGES2PRKDCMAPT | |
| SCHEMBL23349502 | 0.94 | ALOX5 (0.51) | ALOX5GGPS1PTGES2PRKDCMAPT | |
| SCHEMBL24216317 | 0.94 | ALOX5 (0.51) | ALOX5GGPS1PTGES2PRKDCMAPT | |
| SCHEMBL24216334 | 0.94 | ALOX5 (0.51) | ALOX5GGPS1PTGES2PRKDCMAPT | |
| SCHEMBL24216262 | 0.94 | ALOX5 (0.51) | ALOX5GGPS1PTGES2PRKDCMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11691966-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-07-04 | — | — | US | disclosed |
| US-11691966-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-07-04 | — | — | US | disclosed |
| US-20200231581-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2020-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11691966-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | PIEZO1, OR51E2, OR10J3 | ALOX5 953/4885GGPS1 2015/4885PTGES2 1278/4885 |
| US-20200231581-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | PIEZO1, OR51E2, OR10J3 | ALOX5 953/4885GGPS1 2015/4885PTGES2 1278/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.